POSTER: MM-1162 Trial in Progress: Quintessential-2A—A Phase 3 Study of Arlocabtagene Autoleucel Versus Standard of Care in Adult Patients With Relapsed and Refractory Multiple Myeloma Refractory to Lenalidomide | Publicación